glp-1 treatment milwaukee Agonists: Revolutionizing the of Obesity, but Are They Enough? - Eric Velazquez, MD - Bariatric Surgeon - Longstreet Clinic Center for Weight Management GLP-1 Weight Loss Program |

[DOI] [PMC free article] [PubMed] [Google Scholar] 122.Gupta U, Gupta Y, Jose D, et al

To sum up, GLP-1RAs improve cardiomyocyte/cardiac fibroblast dysfunction by making balancing energy metabolism, and multiple pathways related to AMPK to inhibit cardiac apoptosis

10.1002/jmv.20427 45 HansenH

Prior to this several other anti-obesity drugs had also proven disappointing due to adverse effects such as cardiovascular problems, increased suicidal risk and enhanced drug dependence and abuse (Mller, Blher, Tschp, DiMarchi)

Unlike traditional interventions such as low-calorie diets or behavioral counseling, which often result in 30% weight regain within one year, pharmacologic agents like semaglutide and tirzepatide have demonstrated durable weight reductions of 10-20%, alongside improvements in cardiometabolic risk factors, such as blood pressure, HbA1c, and lipid profiles